Michael V. O’Shaughnessy

rutgers university biomedical & health sciences

64H指数

286论文数

1.3W被引数

收录论文 58

发表时间

RT-PCR negative COVID-19

BMC INFECTIOUS DISEASES

IF3

2022-02-13

OAAI

Parmar, Heta; Montovano, Margaret; Banada, Padmapriya; Pentakota, Sri Ram; Shiau, Stephanie; Ma, Zhongjie; Saibire, Kaheerman; Chopoorian, Abby; O'Shaughnessy, Michael; Hirsch, Mitchell; Jain, Priyanshi; Demirdjian, Gaiane; Karagueuzian, Magali; Robin, Thomas; Salvati, Michael; Patel, Bhavana; Alland, David; Xie, Yingda L.

PICTURE QUIZ A hand flexion contracture with progression

BMJ-BRITISH MEDICAL JOURNAL

IF42.7

2014-10-30

PREAI

McInerney, Niall M.; O'Shaughnessy, Michael; Clover, James

Deadly Public Policy: What the Future Could Hold for the HIV Epidemic among Injection Drug Users in Vancouver

CURRENT HIV/AIDS REPORTS

IF4.4

2012-07-08

PREAI

O'Shaughnessy, Michael V.; Hogg, Robert S.; Strathdee, Steffanie A.; Montaner, Julio S. G.

The Use of Ultrasound in Evaluating Flexor Tendons following Surgical Repair

PLASTIC AND RECONSTRUCTIVE SURGERY

IF3.4

2012-02-01

OAAI

Nugent, Nora; Coyle, Joseph; Barry, Josephine; O'Shaughnessy, Michael

CLINICAL INFECTIOUS DISEASES

IF7.3

2004-03-01

OAAI

Montaner, JSG; Côté, HCF; Harris, M; Hogg, RS; Yip, B; Harrigan, PR; O'Shaughnessy, MV

Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studies

AIDS

IF3.1

2003-12-01

OAAI

Wood, E; Hogg, RS; Heath, KV; de la Rosa, R; Lee, N; Yip, B; O'Shaughnessy, MV; Montaner, JSG

Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 X 109 cells/L

ANNALS OF INTERNAL MEDICINE

IF15.2

2003-11-18

340

PREAI

Wood, E; Hogg, RS; Yip, B; Harrigan, PR; O'Shaughnessy, MV; Montaner, JSG

Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapy

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2003-11-15

OAAI

Wood, E; Hogg, RS; Yip, B; Quercia, R; Harrigan, PR; O'Shaughnessy, MV; Montaner, JSG

Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world

AIDS

IF3.1

2003-11-01

OAAI

Wood, E; Montaner, JSG; Bangsberg, DR; Tyndall, MW; Strathdee, SA; O'Shaughnessy, MV; Hogg, RS

Prevalence and correlates of untreated human immunodeficiency virus type 1 infection among persons who have died in the era of modern antiretroviral therapy

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2003-10-15

OAAI

Wood, E; Montaner, JSG; Tyndall, MW; Schechter, MT; O'Shaughnessy, MV; Hogg, RS

Interventional cardiovascular procedures among HIV-infected individuals on antiretroviral therapy 1995-2000

AIDS

IF3.1

2003-09-01

OAAI

Braitstein, P; Yip, B; Heath, KV; Levy, AR; Montaner, JSG; Humphries, K; Kiely, FM; O'Shaughnessy, MV; Hogg, RS

Antiretroviral concentrations in untimed plasma samples predict therapy outcome in a population with advanced disease

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2003-08-15

OAAI

Alexander, CS; Asselin, JJ; Ting, LSL; Montaner, JSG; Hogg, RS; Yip, B; O'Shaughnessy, MV; Harrigan, PR

Sexual violence among a cohort of injection drug users

SOCIAL SCIENCE & MEDICINE

IF5

2003-08-01

105

OAAI

Braitstein, P; Li, K; Tyndall, M; Spittal, P; O'Shaughnessy, MV; Schilder, A; Johnston, C; Hogg, RS; Schechter, MT

Sources and magnitude of intralaboratory variability in a sequence-based genotypic assay for human immunodeficiency virus type 1 drug resistance

JOURNAL OF CLINICAL MICROBIOLOGY

IF5.4

2003-07-01

OAAI

Galli, RA; Sattha, B; Wynhoven, B; O'Shaughnessy, MV; Harrigan, PR

Rates of disease progression among human immunodeficiency virus-infected persons initiating multiple-drug rescue therapy

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2003-07-01

OAAI

Lee, N; Hogg, RS; Yip, B; Harrigan, PR; Harris, M; O'Shaughnessy, MV; Montaner, JSG

Mitochondrial:nuclear DNA ratios in peripheral blood cells from human immunodeficiency virus (HIV)-infected patients who received selected HIV antiretroviral drug regimens

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2003-06-15

PREAI

Côté, HCF; Yip, B; Asselin, JJ; Chan, JW; Hogg, RS; Harrigan, PR; O'Shaughnessy, MV; Montaner, JSG

Predictors of early hospital readmission in HIV-infected patients with pneumonia

JOURNAL OF GENERAL INTERNAL MEDICINE

IF4.2

2003-04-01

OAAI

Palepu, A; Sun, HY; Kuyper, L; Schechter, MT; O'Shaughnessy, MV; Anis, AH

Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic

AIDS

IF3.1

2003-04-01

330

OAAI

Tyndall, MW; Currie, S; Spittal, P; Li, K; Wood, E; O'Shaughnessy , MV; Schechter, MT

Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response

AIDS

IF3.1

2003-01-01

OAAI

Brumme, ZL; Dong, WWY; Chan, KJ; Hogg, RS; Montaner, JSG; O'Shaughnessy, MV; Harrigan, PR

Time to act: global apathy towards HIV/AIDS is a crime against humanity

LANCET

IF88.5

2002-11-01

PREAI

Hogg, R; Cahn, P; Katabira, ET; Lange, J; Samuel, NM; O'Shaughnessy, M; Vella, S; Wainberg, MA; Montaner, J

研究方向